Benzinga | Dec 10, 2020 12:36PM EST

UBS Initiates Coverage On AdaptHealth with Buy Rating, Announces Price Target of $49

UBS analyst Whit Mayo initiates coverage on AdaptHealth (NASDAQ:AHCO) with a Buy rating and announces Price Target of $49.